Baseline Blood CD8 ⁺ T Cell Activation Potency Discriminates Responders from Non-Responders to Immune Checkpoint Inhibition Combined with Stereotactic Radiotherapy in Non-Small-Cell Lung Cancer.

Autor: Kievit H; Department of Pulmonology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Muntinghe-Wagenaar MB; Department of Pulmonology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Abdulahad WH; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Rutgers A; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Hijmering-Kappelle LBM; Department of Pulmonology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Hiddinga BI; Department of Pulmonology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Ubbels JF; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Wijsman R; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., van der Leij MJ; Department of Laboratory Medicine, Medical Immunology Laboratory, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Bijzet J; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Groen HJM; Department of Pulmonology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Kerstjens HAM; Department of Pulmonology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., van der Wekken AJ; Department of Pulmonology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Kroesen BJ; Department of Laboratory Medicine, Medical Immunology Laboratory, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Hiltermann TJN; Department of Pulmonology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.

Publikováno v: Cancers [Cancers (Basel)] 2024 Jul 19; Vol. 16 (14). Date of Electronic Publication: 2024 Jul 19.

Longitudinal analysis of serum neurofilament light chain levels as marker for neuronal damage in hereditary transthyretin amyloidosis.

Autor: Berends M; Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands.; Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands., Brunger AF; Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands.; Department of Rheumatology & Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands., Bijzet J; Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands.; Department of Laboratory Medicine, University Medical Center Groningen, Groningen, The Netherlands., Kroesen BJ; Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands.; Department of Laboratory Medicine, University Medical Center Groningen, Groningen, The Netherlands., Drost G; Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands.; Department of Neurology, University Medical Center Groningen, Groningen, The Netherlands., Lange F; Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands.; Department of Neurology, University Medical Center Groningen, Groningen, The Netherlands., Teunissen CE; Department of Laboratory Medicine, Amsterdam Neuroscience, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., In 't Veld S; Department of Laboratory Medicine, Amsterdam Neuroscience, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., Vrancken AF; Department of Neurology, University Medical Center Utrecht, Utrecht, The Netherlands., Gans ROB; Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands.; Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands., Hazenberg BPC; Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands.; Department of Rheumatology & Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands., van der Zwaag PA; Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands.; Department of Medical Genetics, University Medical Center Groningen, Groningen, The Netherlands., Nienhuis HLA; Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands.; Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands.

Publikováno v: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis [Amyloid] 2024 Jun; Vol. 31 (2), pp. 132-141. Date of Electronic Publication: 2024 Mar 13.

Ellipro scores of donor epitope specific HLA antibodies are not associated with kidney graft survival.

Autor: Kardol-Hoefnagel T; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Senejohnny DM; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Kamburova EG; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Wisse BW; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Gruijters ML; Renal Transplant Unit, Department of Internal Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands., Joosten I; Laboratory Medicine, Laboratory of Medical Immunology, Radboud University Medical Center, Nijmegen, The Netherlands., Allebes WA; Laboratory Medicine, Laboratory of Medical Immunology, Radboud University Medical Center, Nijmegen, The Netherlands., van der Meer A; Laboratory Medicine, Laboratory of Medical Immunology, Radboud University Medical Center, Nijmegen, The Netherlands., Hilbrands LB; Department of Nephrology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., Baas MC; Department of Nephrology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., Spierings E; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.; Central Diagnostic Laboratory (CDL), University Medical Center Utrecht, Utrecht, The Netherlands., Hack CE; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., van Reekum FE; Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands., van Zuilen AD; Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands., Verhaar MC; Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands., Drop ACAD; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Plaisier L; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Melchers RCA; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Seelen MAJ; Department of Nephrology, University Medical Center Groningen, Groningen, The Netherlands., Sanders JS; Department of Nephrology, University Medical Center Groningen, Groningen, The Netherlands., Hepkema BG; Department of Laboratory Medicine, University Medical Center Groningen, Groningen, The Netherlands., Kroesen BJ; Department of Laboratory Medicine, University Medical Center Groningen, Groningen, The Netherlands., Bungener LB; Department of Laboratory Medicine, University Medical Center Groningen, Groningen, The Netherlands., Roozendaal C; Department of Laboratory Medicine, University Medical Center Groningen, Groningen, The Netherlands., Tilanus MGJ; Department of Transplantation Immunology, Tissue Typing Laboratory, Maastricht University Medical Center, Maastricht, The Netherlands., Voorter CE; Department of Transplantation Immunology, Tissue Typing Laboratory, Maastricht University Medical Center, Maastricht, The Netherlands., Wieten L; Department of Transplantation Immunology, Tissue Typing Laboratory, Maastricht University Medical Center, Maastricht, The Netherlands., van Duijnhoven EM; Department of Internal Medicine, Division of Nephrology, Maastricht University Medical Center, Maastricht, The Netherlands., Gelens MACJ; Department of Internal Medicine, Division of Nephrology, Maastricht University Medical Center, Maastricht, The Netherlands., Christiaans MHL; Department of Internal Medicine, Division of Nephrology, Maastricht University Medical Center, Maastricht, The Netherlands., van Ittersum FJ; Department of Nephrology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Nurmohamed SA; Department of Nephrology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Lardy NM; Department of Immunogenetics, Sanquin Diagnostic Services, Amsterdam, The Netherlands., Swelsen W; Department of Immunogenetics, Sanquin Diagnostic Services, Amsterdam, The Netherlands., van der Pant KAMI; Renal Transplant Unit, Department of Internal Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands., van der Weerd NC; Renal Transplant Unit, Department of Internal Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands., Ten Berge IJM; Renal Transplant Unit, Department of Internal Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands., Hoitsma A; Dutch Organ Transplant Registry (NOTR), Dutch Transplant Foundation (NTS), Leiden, The Netherlands., van der Boog PJM; Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands., de Fijter JW; Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands., Betjes MGH; Department of Nephrology, Erasmus Medical Center, Rotterdam, Rotterdam, The Netherlands., Roelen DL; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., Claas FH; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., Bemelman FJ; Renal Transplant Unit, Department of Internal Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands., Heidt S; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., Otten HG; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.; Central Diagnostic Laboratory (CDL), University Medical Center Utrecht, Utrecht, The Netherlands.

Publikováno v: HLA [HLA] 2024 Jan; Vol. 103 (1), pp. e15297.

Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD.

Autor: Muiser S; Department of Pulmonology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands s.muiser@umcg.nl.; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Imkamp K; Department of Pulmonology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Seigers D; Department of Pulmonology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Halbersma NJ; Department of Pulmonology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Vonk JM; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.; Department of Epidemiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Luijk BHD; Department of Pulmonology, University Medical Centre Utrecht, Utrecht, The Netherlands., Braunstahl GJ; Department of Pulmonology, Franciscus Gasthuis, Rotterdam, The Netherlands., van den Berg JW; Department of Pulmonology, Isala Hospital, Zwolle, The Netherlands., Kroesen BJ; Laboratory of Medical Immunology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Kocks JWH; Department of Pulmonology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.; General Practitioners Research Institute, Groningen, The Netherlands.; Observational and Pragmatic Research Institute Pte Ltd, Singapore., Heijink IH; Department of Pulmonology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.; Department of Pathology and Medical Biology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Reddel HK; Woolcock Institute of Medical Research, Glebe, New South Wales, Australia.; The University of Sydney, Sydney, New South Wales, Australia., Kerstjens HAM; Department of Pulmonology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., van den Berge M; Department of Pulmonology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.

Publikováno v: Thorax [Thorax] 2023 May; Vol. 78 (5), pp. 451-458. Date of Electronic Publication: 2023 Feb 01.

Neurofilament light chain, a biomarker for polyneuropathy in systemic amyloidosis.

Autor: Louwsma J; Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands.; Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands., Brunger AF; Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands.; Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands., Bijzet J; Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands.; Department of Rheumatology & Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands., Kroesen BJ; Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands.; Department of Laboratory medicine, University Medical Center Groningen, Groningen, The Netherlands., Roeloffzen WWH; Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands.; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Bischof A; Department of Neurology, University Hospital Basel, Basel, Switzerland., Kuhle J; Department of Neurology, University Hospital Basel, Basel, Switzerland., Drost G; Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands.; Department of Neurology, University Medical Center Groningen, Groningen, The Netherlands., Lange F; Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands.; Department of Neurology, University Medical Center Groningen, Groningen, The Netherlands., Kuks JBM; Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands.; Department of Neurology, University Medical Center Groningen, Groningen, The Netherlands., Gans ROB; Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands.; Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands., Hazenberg BPC; Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands.; Department of Rheumatology & Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands., Nienhuis HLA; Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands.; Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands.

Publikováno v: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis [Amyloid] 2021 Mar; Vol. 28 (1), pp. 50-55. Date of Electronic Publication: 2020 Sep 04.